Rosalind A. Eeles

88.2k total citations · 5 hit papers
361 papers, 17.7k citations indexed

About

Rosalind A. Eeles is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Rosalind A. Eeles has authored 361 papers receiving a total of 17.7k indexed citations (citations by other indexed papers that have themselves been cited), including 186 papers in Genetics, 123 papers in Pulmonary and Respiratory Medicine and 106 papers in Molecular Biology. Recurrent topics in Rosalind A. Eeles's work include BRCA gene mutations in cancer (139 papers), Prostate Cancer Treatment and Research (99 papers) and Prostate Cancer Diagnosis and Treatment (67 papers). Rosalind A. Eeles is often cited by papers focused on BRCA gene mutations in cancer (139 papers), Prostate Cancer Treatment and Research (99 papers) and Prostate Cancer Diagnosis and Treatment (67 papers). Rosalind A. Eeles collaborates with scholars based in United Kingdom, United States and Canada. Rosalind A. Eeles's co-authors include Douglas F. Easton, Audrey Ardern‐Jones, Zsofia Kote‐Jarai, Maggie Watson, Magali Olivier, Pierre Hainaut, D. Gareth Evans, Khan Ma, Curtis C. Harris and Monica Hollstein and has published in prestigious journals such as Science, The Lancet and Nature Communications.

In The Last Decade

Rosalind A. Eeles

350 papers receiving 17.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The IARC TP53 database: New online mutation analysis and recommendations to users

2002 980 citations Rosalind A. Eeles et al. profile →
Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS)

2005 765 citations Caroline Boggis, Douglas F. Easton et al. profile →
Prostate cancer

2015 708 citations Chris Parker, Rosalind A. Eeles et al. profile →
Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial

1998 649 citations Rosalind A. Eeles, Mitch Dowsett et al. profile →
Stereotactic body radiotherapy for oligometastases

2012 374 citations Alison Tree, Vincent Khoo et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Rosalind A. Eeles	7.0k	5.8k	5.7k	4.7k	3.9k	361	17.7k
Paul D.P. Pharoah	6.1k 0.9×	7.3k 1.2×	6.7k 1.2×	2.7k 0.6×	4.8k 1.2×	340	19.9k
Mark E. Robson	9.1k 1.3×	5.9k 1.0×	8.0k 1.4×	3.4k 0.7×	6.0k 1.5×	412	19.5k
Olufunmilayo I. Olopade	7.4k 1.1×	7.1k 1.2×	7.5k 1.3×	2.0k 0.4×	6.3k 1.6×	420	20.0k
Susan M. Domchek	8.8k 1.3×	6.0k 1.0×	10.2k 1.8×	3.0k 0.6×	4.9k 1.3×	334	19.7k
Jan G.M. Klijn	5.8k 0.8×	6.7k 1.2×	6.1k 1.1×	1.6k 0.3×	6.0k 1.5×	148	16.8k
Susan G. Hilsenbeck	4.7k 0.7×	10.0k 1.7×	9.8k 1.7×	3.4k 0.7×	5.6k 1.4×	340	21.9k
Bella Kaufman	2.6k 0.4×	4.4k 0.7×	8.1k 1.4×	3.7k 0.8×	3.2k 0.8×	250	15.2k
Christopher I. Amos	5.3k 0.8×	7.6k 1.3×	4.5k 0.8×	2.8k 0.6×	3.2k 0.8×	544	18.6k
David Cameron	3.5k 0.5×	5.6k 1.0×	13.6k 2.4×	4.8k 1.0×	7.0k 1.8×	533	23.8k
Timothy R. Rebbeck	5.6k 0.8×	3.0k 0.5×	3.7k 0.7×	2.0k 0.4×	2.7k 0.7×	257	12.7k

Countries citing papers authored by Rosalind A. Eeles

Since Specialization

Citations

This map shows the geographic impact of Rosalind A. Eeles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosalind A. Eeles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosalind A. Eeles more than expected).

Fields of papers citing papers by Rosalind A. Eeles

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosalind A. Eeles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosalind A. Eeles. The network helps show where Rosalind A. Eeles may publish in the future.

Co-authorship network of co-authors of Rosalind A. Eeles

This figure shows the co-authorship network connecting the top 25 collaborators of Rosalind A. Eeles. A scholar is included among the top collaborators of Rosalind A. Eeles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosalind A. Eeles. Rosalind A. Eeles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gihawi, Abraham, Henry M. Wood, J. W. Clark, et al.. (2025). The landscape of microbial associations in human cancer. Science Translational Medicine. 17(814). eads6166–eads6166. 2 indexed citations

Howlett, Sarah, Louise Brown, Claire Amos, et al.. (2024). 1656TiP The STAMPEDE2 niraparib-abiraterone acetate + prednisolone trial: A phase III, randomised, open-label trial in patients with metastatic prostate cancer (mPC) with a deleterious alteration in a homologous recombination repair (HRR) gene starting androgen deprivation therapy (ADT). Annals of Oncology. 35. S998–S999. 1 indexed citations

Sobočan, Monika, et al.. (2024). Online Provision of BRCA1 and BRCA2 Health Information: A Search Engine Driven Systematic Web-Based Analysis. Cancers. 16(13). 2324–2324.

Mutambirwa, Shingai B.A., Zsofia Kote‐Jarai, Weerachai Jaratlerdsiri, et al.. (2023). Evaluating Germline Testing Panels in Southern African Males With Advanced Prostate Cancer. Journal of the National Comprehensive Cancer Network. 21(3). 289–296.e3. 13 indexed citations

Boonen, Rick A.C.M., Wouter W. Wiegant, Bas Vroling, et al.. (2021). Functional Analysis Identifies Damaging CHEK2 Missense Variants Associated with Increased Cancer Risk. Cancer Research. 82(4). 615–631. 33 indexed citations

Petralia, Giuseppe, Dow‐Mu Koh, Rosalind A. Eeles, et al.. (2021). Oncologically Relevant Findings Reporting and Data System (ONCO-RADS): Guidelines for the Acquisition, Interpretation, and Reporting of Whole-Body MRI for Cancer Screening. Radiology. 299(3). 494–507. 39 indexed citations

Wu, Lang, Xiang Shu, Jiandong Bao, et al.. (2019). Analysis of Over 140,000 European Descendants Identifies Genetically Predicted Blood Protein Biomarkers Associated with Prostate Cancer Risk. Cancer Research. 79(18). 4592–4598. 16 indexed citations

Wu, Lang, Jifeng Wang, Qiuyin Cai, et al.. (2019). Identification of Novel Susceptibility Loci and Genes for Prostate Cancer Risk: A Transcriptome-Wide Association Study in Over 140,000 European Descendants. Cancer Research. 79(13). 3192–3204. 37 indexed citations

Brand, Douglas, David P. Dearnaley, Rosalind A. Eeles, et al.. (2019). Patterns of recurrence after prostate bed radiotherapy. Radiotherapy and Oncology. 141. 174–180. 15 indexed citations

10.

Callender, Thomas, Mark Emberton, Stephen Morris, et al.. (2019). Polygenic risk-tailored screening for prostate cancer: A benefit–harm and cost-effectiveness modelling study. PLoS Medicine. 16(12). e1002998–e1002998. 48 indexed citations

11.

Loveday, Chey, Amit Sud, Kevin Litchfield, et al.. (2019). Runs of homozygosity and testicular cancer risk. Andrology. 7(4). 555–564. 4 indexed citations

12.

Howell, Anthony, Linda Ashcroft, Lesley Fallowfield, et al.. (2017). RAZOR: A Phase II Open Randomized Trial of Screening Plus Goserelin and Raloxifene Versus Screening Alone in Premenopausal Women at Increased Risk of Breast Cancer. Cancer Epidemiology Biomarkers & Prevention. 27(1). 58–66. 4 indexed citations

13.

Tóth, Réka, Dominique Scherer, Linda E. Kelemen, et al.. (2017). Genetic Variants in Epigenetic Pathways and Risks of Multiple Cancers in the GAME-ON Consortium. Cancer Epidemiology Biomarkers & Prevention. 26(6). 816–825. 11 indexed citations

14.

MacInnis, Robert J., Daniel F. Schmidt, Enes Makalic, et al.. (2016). Use of a Novel Nonparametric Version of DEPTH to Identify Genomic Regions Associated with Prostate Cancer Risk. Cancer Epidemiology Biomarkers & Prevention. 25(12). 1619–1624. 3 indexed citations

15.

Pashayan, Nora, Stephen Duffy, David E. Neal, et al.. (2015). Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis. Genetics in Medicine. 17(10). 789–795. 69 indexed citations

16.

Knipe, Duleeka, David M. Evans, John P. Kemp, et al.. (2014). Genetic Variation in Prostate-Specific Antigen–Detected Prostate Cancer and the Effect of Control Selection on Genetic Association Studies. Cancer Epidemiology Biomarkers & Prevention. 23(7). 1356–1365. 25 indexed citations

17.

Kauff, Noah D., Susan M. Domchek, Tara M. Friebel, et al.. (2008). Risk-Reducing Salpingo-Oophorectomy for the Prevention of BRCA1- and BRCA2-Associated Breast and Gynecologic Cancer: A Multicenter, Prospective Study. Journal of Clinical Oncology. 26(8). 1331–1337. 381 indexed citations

18.

Watson, Maggie, Kathryn M. Kash, Judi Homewood, et al.. (2005). Does Genetic Counseling Have Any Impact on Management of Breast Cancer Risk?. Genetic Testing. 9(2). 167–174. 28 indexed citations

19.

Foster, Claire, D. Gareth Evans, Rosalind A. Eeles, et al.. (2004). Non-Uptake of Predictive Genetic Testing for BRCA1/2 among Relatives of Known Carriers: Attributes, Cancer Worry, and Barriers to Testing in a Multicenter Clinical Cohort. Genetic Testing. 8(1). 23–29. 56 indexed citations

20.

Hallowell, Nina, Claire Foster, Audrey Ardern‐Jones, et al.. (2002). Genetic Testing for Women Previously Diagnosed with Breast/Ovarian Cancer: Examining the Impact of BRCA1 and BRCA2 Mutation Searching. Genetic Testing. 6(2). 79–87. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact